全文获取类型
收费全文 | 24417篇 |
免费 | 1725篇 |
国内免费 | 564篇 |
专业分类
耳鼻咽喉 | 175篇 |
儿科学 | 1183篇 |
妇产科学 | 365篇 |
基础医学 | 2054篇 |
口腔科学 | 81篇 |
临床医学 | 2977篇 |
内科学 | 3217篇 |
皮肤病学 | 126篇 |
神经病学 | 1248篇 |
特种医学 | 850篇 |
外国民族医学 | 3篇 |
外科学 | 4274篇 |
综合类 | 3390篇 |
现状与发展 | 3篇 |
预防医学 | 2084篇 |
眼科学 | 45篇 |
药学 | 2458篇 |
18篇 | |
中国医学 | 654篇 |
肿瘤学 | 1501篇 |
出版年
2024年 | 19篇 |
2023年 | 347篇 |
2022年 | 535篇 |
2021年 | 880篇 |
2020年 | 891篇 |
2019年 | 857篇 |
2018年 | 877篇 |
2017年 | 815篇 |
2016年 | 848篇 |
2015年 | 862篇 |
2014年 | 1707篇 |
2013年 | 1716篇 |
2012年 | 1511篇 |
2011年 | 1561篇 |
2010年 | 1270篇 |
2009年 | 1210篇 |
2008年 | 1229篇 |
2007年 | 1233篇 |
2006年 | 1085篇 |
2005年 | 946篇 |
2004年 | 797篇 |
2003年 | 662篇 |
2002年 | 577篇 |
2001年 | 508篇 |
2000年 | 397篇 |
1999年 | 370篇 |
1998年 | 303篇 |
1997年 | 259篇 |
1996年 | 205篇 |
1995年 | 203篇 |
1994年 | 191篇 |
1993年 | 169篇 |
1992年 | 184篇 |
1991年 | 147篇 |
1990年 | 134篇 |
1989年 | 118篇 |
1988年 | 105篇 |
1987年 | 92篇 |
1986年 | 110篇 |
1985年 | 132篇 |
1984年 | 109篇 |
1983年 | 84篇 |
1982年 | 110篇 |
1981年 | 82篇 |
1980年 | 62篇 |
1979年 | 40篇 |
1978年 | 38篇 |
1977年 | 30篇 |
1976年 | 24篇 |
1973年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献
2.
3.
目的:探讨消化道肿瘤中同源重组修复相关基因(homologous recombination repair related gene,HRR)突变的发生情况及临床意义。方法:共92例消化道肿瘤患者,79例患者进行了血液标本HRR检测,53例患者进行了组织标本HRR检测,40例患者同时行血液和组织的HRR基因检测,收集患者基因检测结果及临床相关资料。结果:在79例患者血液标本检测中发现10例(12.6%)有临床意义HRR突变,在53例患者组织标本检测中发现9例(17.0%)有临床意义HRR突变。40例同时行血液和组织的HRR基因检测患者中常见的有临床意义HRR突变为CDK12突变4例(10.0%)、ATM突变3例(7.5%)、BRCA1突变2例(5.0%)。13例有临床意义HRR突变患者中常见共存突变为TP53突变10例(76.9%)、APC突变5例(38.5%)、PIK3CA突变4例(30.8%)。40例患者中13例患者血液和/或组织中有临床意义HRR突变,27例患者血液和组织中均无任何临床意义HRR突变且两组相比,有临床意义HRR突变组肿瘤突变负荷(tumor mutational burden,TMB)为6.17(2.24~11.52),而未携带HRR突变组TMB为0.4(0~3.75),差异有统计学意义(P<0.05)。40例患者组织检测中7例HRR有临床意义的突变,33例无HRR突变,血液检测中10例HRR有临床意义的突变,30例无HRR突变,一致性检验的Kappa值为0.333(P=0.031)。结论:携带有临床意义HRR突变的消化道肿瘤患者TMB更高,血液和组织检测HRR突变有较好的一致性。 相似文献
4.
《Drug discovery today》2022,27(4):1196-1203
Immuno-positron emission tomography (immunoPET) imaging is a paradigm-shifting imaging technique for whole-body and all-lesion tumor detection, based on the combined specificity of tumor-targeting vectors [e.g., monoclonal antibodies (mAbs), nanobodies, and bispecific antibodies] and the sensitivity of PET imaging. By noninvasively, comprehensively, and serially revealing heterogeneous tumor antigen expression, immunoPET imaging is gradually improving the theranostic prospects for hematological malignancies. In this review, we summarize the available literature regarding immunoPET in imaging hematological malignancies. We also highlight the pros and cons of current conjugation strategies, and modular chemistry that can be leveraged to develop novel immunoPET probes for hematological malignancies. Lastly, we discuss the use of immunoPET imaging in guiding antibody drug development. 相似文献
5.
6.
7.
8.
9.
Aldo Cannata Silvia Cantoni Antonio Sciortino Giuseppe Bruschi Claudio Francesco Russo 《Journal of the American College of Cardiology》2021,77(18):2323-2334
Mechanical intravascular hemolysis is frequently observed following procedures on heart valves and uncommonly observed in native valvular disease. In most cases, its severity is mild. Nevertheless, it can be clinically significant and even life threatening, requiring multiple blood transfusions and renal replacement therapy. This paper reviews the current knowledge on mechanical intravascular hemolysis in valvular disease, before and after correction, focusing on pathophysiology, approach to diagnosis, and impact of other hematological conditions on the resultant anemia. The importance of a multidisciplinary management is underscored. Laboratory data are provided about subclinical hemolysis that is commonly observed following the implantation of surgical and transcatheter valve prostheses and devices. Finally, clinical scenarios are reviewed and current medical and surgical treatments are discussed, including alternative options for inoperable patients. 相似文献
10.